Short Film about UW technology “tumor paint” competing in Sundance Festival

A short (3 min) film about Tumor Paint, a technology invented by the UW, Fred Hutch, and Children’s Hospital, has been created and submitted to the Sundance Film Festival. Tumor Paint makes cancer cells in the brain light up so that they can be more easily identified and removed during surgery such that more healthy tissue can be preserved. The film is a semi-finalist for the Film Festival, and is helping raise awareness of Tumor Paint and its potential to help patients.

You can view the film here:

About Tumor Paint
For years, surgeons have been searching for better intraoperative tools to more effectively treat cancer. When removing tumors, the ability to precisely identify them is of paramount importance. If too little tissue is removed, cancer cells are left behind to grow and spread. If too much tissue is removed, the patient may experience significant disabilities and reduced quality of life. Despite advances in intraoperative monitoring and image guidance, postoperative scans sometimes reveal bulky residual tumor that may have been resected safely if surgeons had improved tools to distinguish tumor tissue from normal tissue.

A team of neurosurgeons, engineers and biologists at the UW, Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital Research Institute, led by Dr. Jim Olson, has created a technology that illuminates cancer cells distinguishing tumors from healthy tissue. Tumor Paint technology will enable surgeons to see tumors “live” during surgery at greatly improved resolution over pre-operative MRI or direct intra-operative observation, giving the surgeons a better chance of removing all of the cancerous cells without injuring surrounding healthy tissue.

Blaze Bioscience was founded in 2010 to develop and commercialize Tumor Paint technology, which has the potential to fundamentally transform surgical oncology.